EUVIMEDEUVIMED entdecken
Crossref

L26/P-819 Comparison of three ovulation triggering strategies in normo-responder IVF cycles

B.P. Keskinsoy, E. Pabuccu, G. Israfilova, A. Erdem, M. Erdem, G. Onalan, F. Acet, E. Tavmergen, R. Pabuccu

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B.P. Keskinsoy und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does the timing and combination of GnRH agonist trigger with hCG (dual or sequential) improve oocyte maturation compared to hCG-alone in normo-responder IVF patients? Summary answer Neither dual (simultaneous hCG+GnRHa) nor sequential (GnRHa followed by hCG) triggering improved oocyte maturation rates compared to standard hCG-alone protocol in normo-responders. What is known already The physiological mid-cycle gonadotropin surge includes both LH and FSH components. Dual-trigger and sequential-trigger strategies have been proposed to enhance oocyte meiotic competence by better mimicking the natural FSH surge. While these modified protocols show promise in poor responders and high-risk OHSS patients, their benefit in normo-responder populations remains unclear. Most existing studies compare only two protocols, limiting comprehensive understanding of optimal triggering strategies. Study design, size, duration This multicenter retrospective cohort study analyzed 974 normo-responder IVF cycles conducted between January 2020 and December 2024 across three tertiary reproductive medicine centers in Turkey, directly comparing three distinct triggering protocols. Participants/materials, setting, methods We included normo-responder women aged 20-42 years with AMH 1-4 ng/mL undergoing IVF/ICSI. Three protocols were compared: Group 1 (hCG-alone, n = 405): 6,500 IU recombinant hCG only; Group 2 (dual-trigger, n = 387): simultaneous 6,500 IU hCG + 0.1 mg triptorelin; Group 3 (sequential-trigger, n = 182): 0.1 mg triptorelin followed 4 hours later by 6,500 IU hCG. Primary outcome: oocyte maturation rate. Secondary outcomes: oocyte retrieval and fertilization rates. Propensity score matching adjusted for age, AMH, and AFC. Main results and the role of chance Baseline characteristics differed significantly before adjustment (age p < 0.001, AFC p < 0.001), but were well-balanced after propensity score weighting. After adjustment, mean MII oocytes were similar across protocols: 5.54±3.0 (hCG-alone) vs. 5.70±3.1 (dual) vs. 6.10±3.4 (sequential); p = 0.32. Oocyte maturation rates showed no significant differences between the three groups: 0.82±0.16 (hCG-alone) vs. 0.78±0.18 (dual) vs. 0.74±0.19 (sequential); p = 0.08. COC retrieval was numerically higher with sequential trigger (10.80±4.2 vs. 8.36±3.6 vs. 7.76±3.4) but did not reach statistical significance (p = 0.11). Subgroup analyses stratified by age (<35 vs. ≥35 years) and AMH quartiles consistently showed no significant maturation rate differences across the three triggering protocols. Limitations, reasons for caution Retrospective design limits causal inference. Despite propensity score adjustment, residual confounding cannot be fully excluded. The smaller sample size in Group 3 (sequential-trigger) may have limited statistical power to detect modest differences. Blastocyst development and clinical pregnancy outcomes warrant future investigation. Wider implications of the findings In normo-responder IVF patients, neither dual nor sequential GnRH agonist trigger modifications improved oocyte maturation compared to standard hCG-alone protocol. These findings suggest that routine adoption of more complex dual or sequential triggering strategies may not provide additional benefit in good-prognosis populations, supporting hCG-alone as a simpler, cost-effective option. Trial registration number No

Zitieren

APA

Keskinsoy, B., Pabuccu, E., Israfilova, G., Erdem, A., Erdem, M., Onalan, G., Acet, F., Tavmergen, E., & Pabuccu, R. (2026). L26/P-819 Comparison of three ovulation triggering strategies in normo-responder IVF cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1146

Vancouver

Keskinsoy B, Pabuccu E, Israfilova G, Erdem A, Erdem M, Onalan G, et al. L26/P-819 Comparison of three ovulation triggering strategies in normo-responder IVF cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1146

BibTeX
@article{Keskinsoy2026,
  author = {Keskinsoy, B.P. and Pabuccu, E. and Israfilova, G. and Erdem, A. and Erdem, M. and Onalan, G. and Acet, F. and Tavmergen, E. and Pabuccu, R.},
  title = {L26/P-819 Comparison of three ovulation triggering strategies in normo-responder IVF cycles},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1146}
}
Kostenlos starten →